Global RNA-based Biopharmaceuticals Market Study 2015-2025, by Segment (Therapeutics, Vaccines), by Market (Cancer, Diabetes, Tuberculosis, … …), by Company (Pfizer, Roche, Sanofi-Aventis, … …)
SKU ID :99ST-12624584 | Published Date: 05-Nov-2018 | No. of pages: 65Description
Snapshot
The global RNA-based Biopharmaceuticals market will reach xxx Million USD in 2018 and with a CAGR if xx% between 2019-2025.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Therapeutics
Vaccines
Demand Coverage (Market Size & Forecast, Consumer Distribution):
Cancer
Diabetes
Tuberculosis
Cardiovascular Diseases
Others
Company Coverage (Sales data, Main Products & Services etc.):
Pfizer
Roche
Sanofi-Aventis
Abbott Laboratories
Arrowhead Pharmaceuticals
Benitec Biopharma
Calimmune Inc
Dicerna
Gradalis
Quark
RXi
Senesco
Silence Therapeutics
Silenseed
Tekmira
Alnylam Pharmaceuticals
Major Region Market
North America
Europe
Asia-Pacific
South America
Middle East & Africa
The global RNA-based Biopharmaceuticals market will reach xxx Million USD in 2018 and with a CAGR if xx% between 2019-2025.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Therapeutics
Vaccines
Demand Coverage (Market Size & Forecast, Consumer Distribution):
Cancer
Diabetes
Tuberculosis
Cardiovascular Diseases
Others
Company Coverage (Sales data, Main Products & Services etc.):
Pfizer
Roche
Sanofi-Aventis
Abbott Laboratories
Arrowhead Pharmaceuticals
Benitec Biopharma
Calimmune Inc
Dicerna
Gradalis
Quark
RXi
Senesco
Silence Therapeutics
Silenseed
Tekmira
Alnylam Pharmaceuticals
Major Region Market
North America
Europe
Asia-Pacific
South America
Middle East & Africa
TOC
Tables & Figures
Companies
- PRICE
-
$1800$3600Buy Now